相关实验视频
Updated: Jul 21, 2025

09:44
ATAC-Seq Library Preparation of Murine Bone Marrow-Derived Neutrophils
Published on: January 3, 2025
510
中性粒细胞在动脉样硬化不同阶段的作用
Xiaojing Zhang1, Zhanfang Kang1, Dazhong Yin1
1Department of Basic Medical Research, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan City People's Hospital, Qingyuan, Guangdong, China.
Innate immunity
|July 26, 2023
概括
中性粒细胞,关键的免疫细胞,现在被认为在动脉样硬化发展中的重要作用. 了解它们的机制为预防和治疗这种心血管疾病提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管病理学心血管病理学
- 炎症研究 炎症研究
背景情况:
- 中性粒细胞是主要的免疫反应者,传统上与感染和炎症有关.
- 它们在动脉样硬化病变中的存在以前被低估了,尽管它们在慢性炎症中的理论作用.
- 最近的研究证实了中性粒细胞在小鼠和人类的各种动脉样硬化阶段的参与.
研究的目的:
- 审查中性粒细胞参与动脉样硬化的机制.
- 为了突出中性粒细胞向的动脉样硬化治疗策略.
- 为了强调中性粒细胞在动脉动脉生成和动脉动脉瘤形成中的重要性.
主要方法:
- 对最近关于动脉样硬化的中性粒细胞的研究进行文献综述.
- 分析来自小鼠模型和人类研究的证据.
- 综合了不同疾病阶段中性粒细胞功能的发现.
主要成果:
- 有令人信服的证据表明,在动脉样硬化病变中存在中性粒细胞.
- 中性粒细胞有助于多个阶段的动脉样硬化病理生理学.
- 在动脉样硬化中中性粒细胞作用的具体机制正在被阐明.
结论:
- 中性粒细胞在动脉样硬化中扮演的角色比以前认为的要重要得多.
- 向中性粒细胞为动脉样硬化提供了一个有希望的治疗途径.
- 进一步了解中性粒细胞的作用可以推进动脉动脉生成和动脉动脉瘤的预防和治疗策略.
相关概念视频
Inflammation
53.9K
Overview
53.9K
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis IV: Nursing Management
23
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
23
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K

